Drug intelligence / Profile preview

PY-60

Development stage
Preclinical
Lead developer
University of Illinois Chicago
Modality
Small Molecules
Administration
Inhalation, Intravenous
01

Overview

PY-60 is a small molecule activator of the Yes-associated protein (YAP), a primary effector of the Hippo signaling pathway. It functions by directly binding to Annexin A2 (ANXA2), which facilitates the nuclear translocation and transcriptional activity of YAP. In the context of endothelial biology, PY-60 has been shown to preserve the alveolar-capillary barrier and attenuate lung injury induced by pathogens such as Methicillin-resistant Staphylococcus aureus (MRSA). By promoting YAP signaling, the compound helps maintain the levels of key junctional proteins like VE-cadherin, thereby reducing vascular permeability and pulmonary edema. While currently utilized primarily as a research tool to investigate tissue regeneration and endothelial responses, its mechanism of action suggests potential therapeutic utility in treating acute respiratory distress syndrome (ARDS) and other conditions characterized by barrier dysfunction.

02

Targets

ANXA2 (Annexin A2)YAP1 (YES-associated protein–transcriptional enhancer factor domain complex)

Beyond the preview

Go deeper on PY-60.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PY-60.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call